Immunotherapy Market Report

Global Immunotherapy Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：153
  • REPORT CODE：GMM861310
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Immunotherapy market report explains the definition, types, applications, major countries, and major players of the Immunotherapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Abbvie

    • Bristol-Myers Squibb

    • Amgen Inc

    • Roche

    • Biogen

    • Novartis

    • Pfizer

    • Merck

    • Johnson & Johnson

    • Celgene

    By Type:

    • Monoclonal Antibodies

    • Therapeutic Vaccines

    • Checkpoint Inhibitors

    • Non-Specific Immunotherapy

    By End-User:

    • Oncology

    • Inflammation

    • Central Nervous System

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Immunotherapy Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Immunotherapy Outlook to 2028- Original Forecasts

    • 2.2 Immunotherapy Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Immunotherapy Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Immunotherapy Market- Recent Developments

    • 6.1 Immunotherapy Market News and Developments

    • 6.2 Immunotherapy Market Deals Landscape

    7 Immunotherapy Raw Materials and Cost Structure Analysis

    • 7.1 Immunotherapy Key Raw Materials

    • 7.2 Immunotherapy Price Trend of Key Raw Materials

    • 7.3 Immunotherapy Key Suppliers of Raw Materials

    • 7.4 Immunotherapy Market Concentration Rate of Raw Materials

    • 7.5 Immunotherapy Cost Structure Analysis

      • 7.5.1 Immunotherapy Raw Materials Analysis

      • 7.5.2 Immunotherapy Labor Cost Analysis

      • 7.5.3 Immunotherapy Manufacturing Expenses Analysis

    8 Global Immunotherapy Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Immunotherapy Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Immunotherapy Export by Region (Top 10 Countries) (2017-2028)

    9 Global Immunotherapy Market Outlook by Types and Applications to 2022

    • 9.1 Global Immunotherapy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Therapeutic Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Non-Specific Immunotherapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Immunotherapy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Inflammation Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Central Nervous System Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Immunotherapy Market Analysis and Outlook till 2022

    • 10.1 Global Immunotherapy Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Immunotherapy Consumption (2017-2022)

      • 10.2.2 Canada Immunotherapy Consumption (2017-2022)

      • 10.2.3 Mexico Immunotherapy Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Immunotherapy Consumption (2017-2022)

      • 10.3.2 UK Immunotherapy Consumption (2017-2022)

      • 10.3.3 Spain Immunotherapy Consumption (2017-2022)

      • 10.3.4 Belgium Immunotherapy Consumption (2017-2022)

      • 10.3.5 France Immunotherapy Consumption (2017-2022)

      • 10.3.6 Italy Immunotherapy Consumption (2017-2022)

      • 10.3.7 Denmark Immunotherapy Consumption (2017-2022)

      • 10.3.8 Finland Immunotherapy Consumption (2017-2022)

      • 10.3.9 Norway Immunotherapy Consumption (2017-2022)

      • 10.3.10 Sweden Immunotherapy Consumption (2017-2022)

      • 10.3.11 Poland Immunotherapy Consumption (2017-2022)

      • 10.3.12 Russia Immunotherapy Consumption (2017-2022)

      • 10.3.13 Turkey Immunotherapy Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Immunotherapy Consumption (2017-2022)

      • 10.4.2 Japan Immunotherapy Consumption (2017-2022)

      • 10.4.3 India Immunotherapy Consumption (2017-2022)

      • 10.4.4 South Korea Immunotherapy Consumption (2017-2022)

      • 10.4.5 Pakistan Immunotherapy Consumption (2017-2022)

      • 10.4.6 Bangladesh Immunotherapy Consumption (2017-2022)

      • 10.4.7 Indonesia Immunotherapy Consumption (2017-2022)

      • 10.4.8 Thailand Immunotherapy Consumption (2017-2022)

      • 10.4.9 Singapore Immunotherapy Consumption (2017-2022)

      • 10.4.10 Malaysia Immunotherapy Consumption (2017-2022)

      • 10.4.11 Philippines Immunotherapy Consumption (2017-2022)

      • 10.4.12 Vietnam Immunotherapy Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Immunotherapy Consumption (2017-2022)

      • 10.5.2 Colombia Immunotherapy Consumption (2017-2022)

      • 10.5.3 Chile Immunotherapy Consumption (2017-2022)

      • 10.5.4 Argentina Immunotherapy Consumption (2017-2022)

      • 10.5.5 Venezuela Immunotherapy Consumption (2017-2022)

      • 10.5.6 Peru Immunotherapy Consumption (2017-2022)

      • 10.5.7 Puerto Rico Immunotherapy Consumption (2017-2022)

      • 10.5.8 Ecuador Immunotherapy Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Immunotherapy Consumption (2017-2022)

      • 10.6.2 Kuwait Immunotherapy Consumption (2017-2022)

      • 10.6.3 Oman Immunotherapy Consumption (2017-2022)

      • 10.6.4 Qatar Immunotherapy Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Immunotherapy Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Immunotherapy Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Immunotherapy Consumption (2017-2022)

      • 10.7.2 South Africa Immunotherapy Consumption (2017-2022)

      • 10.7.3 Egypt Immunotherapy Consumption (2017-2022)

      • 10.7.4 Algeria Immunotherapy Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Immunotherapy Consumption (2017-2022)

      • 10.8.2 New Zealand Immunotherapy Consumption (2017-2022)

    11 Global Immunotherapy Competitive Analysis

    • 11.1 Abbvie

      • 11.1.1 Abbvie Company Details

      • 11.1.2 Abbvie Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Abbvie Immunotherapy Main Business and Markets Served

      • 11.1.4 Abbvie Immunotherapy Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Bristol-Myers Squibb

      • 11.2.1 Bristol-Myers Squibb Company Details

      • 11.2.2 Bristol-Myers Squibb Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Bristol-Myers Squibb Immunotherapy Main Business and Markets Served

      • 11.2.4 Bristol-Myers Squibb Immunotherapy Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Amgen Inc

      • 11.3.1 Amgen Inc Company Details

      • 11.3.2 Amgen Inc Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Amgen Inc Immunotherapy Main Business and Markets Served

      • 11.3.4 Amgen Inc Immunotherapy Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Roche

      • 11.4.1 Roche Company Details

      • 11.4.2 Roche Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Roche Immunotherapy Main Business and Markets Served

      • 11.4.4 Roche Immunotherapy Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Biogen

      • 11.5.1 Biogen Company Details

      • 11.5.2 Biogen Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Biogen Immunotherapy Main Business and Markets Served

      • 11.5.4 Biogen Immunotherapy Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Novartis

      • 11.6.1 Novartis Company Details

      • 11.6.2 Novartis Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Novartis Immunotherapy Main Business and Markets Served

      • 11.6.4 Novartis Immunotherapy Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Pfizer

      • 11.7.1 Pfizer Company Details

      • 11.7.2 Pfizer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Pfizer Immunotherapy Main Business and Markets Served

      • 11.7.4 Pfizer Immunotherapy Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Merck

      • 11.8.1 Merck Company Details

      • 11.8.2 Merck Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Merck Immunotherapy Main Business and Markets Served

      • 11.8.4 Merck Immunotherapy Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Johnson & Johnson

      • 11.9.1 Johnson & Johnson Company Details

      • 11.9.2 Johnson & Johnson Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Johnson & Johnson Immunotherapy Main Business and Markets Served

      • 11.9.4 Johnson & Johnson Immunotherapy Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Celgene

      • 11.10.1 Celgene Company Details

      • 11.10.2 Celgene Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Celgene Immunotherapy Main Business and Markets Served

      • 11.10.4 Celgene Immunotherapy Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Immunotherapy Market Outlook by Types and Applications to 2028

    • 12.1 Global Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Therapeutic Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Non-Specific Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Inflammation Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Central Nervous System Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Immunotherapy Market Analysis and Outlook to 2028

    • 13.1 Global Immunotherapy Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Immunotherapy Consumption Forecast (2022-2028)

      • 13.2.2 Canada Immunotherapy Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Immunotherapy Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Immunotherapy Consumption Forecast (2022-2028)

      • 13.3.2 UK Immunotherapy Consumption Forecast (2022-2028)

      • 13.3.3 Spain Immunotherapy Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Immunotherapy Consumption Forecast (2022-2028)

      • 13.3.5 France Immunotherapy Consumption Forecast (2022-2028)

      • 13.3.6 Italy Immunotherapy Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Immunotherapy Consumption Forecast (2022-2028)

      • 13.3.8 Finland Immunotherapy Consumption Forecast (2022-2028)

      • 13.3.9 Norway Immunotherapy Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Immunotherapy Consumption Forecast (2022-2028)

      • 13.3.11 Poland Immunotherapy Consumption Forecast (2022-2028)

      • 13.3.12 Russia Immunotherapy Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Immunotherapy Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Immunotherapy Consumption Forecast (2022-2028)

      • 13.4.2 Japan Immunotherapy Consumption Forecast (2022-2028)

      • 13.4.3 India Immunotherapy Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Immunotherapy Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Immunotherapy Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Immunotherapy Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Immunotherapy Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Immunotherapy Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Immunotherapy Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Immunotherapy Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Immunotherapy Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Immunotherapy Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Immunotherapy Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Immunotherapy Consumption Forecast (2022-2028)

      • 13.5.3 Chile Immunotherapy Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Immunotherapy Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Immunotherapy Consumption Forecast (2022-2028)

      • 13.5.6 Peru Immunotherapy Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Immunotherapy Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Immunotherapy Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Immunotherapy Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Immunotherapy Consumption Forecast (2022-2028)

      • 13.6.3 Oman Immunotherapy Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Immunotherapy Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Immunotherapy Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Immunotherapy Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Immunotherapy Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Immunotherapy Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Immunotherapy Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Immunotherapy Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Immunotherapy Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Immunotherapy Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Immunotherapy

    • Figure of Immunotherapy Picture

    • Table Global Immunotherapy Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Immunotherapy Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Specific Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Inflammation Consumption and Growth Rate (2017-2022)

    • Figure Global Central Nervous System Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption by Country (2017-2022)

    • Table North America Immunotherapy Consumption by Country (2017-2022)

    • Figure United States Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Canada Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Mexico Immunotherapy Consumption and Growth Rate (2017-2022)

    • Table Europe Immunotherapy Consumption by Country (2017-2022)

    • Figure Germany Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure UK Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Spain Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Belgium Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure France Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Italy Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Denmark Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Finland Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Norway Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Sweden Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Poland Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Russia Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Turkey Immunotherapy Consumption and Growth Rate (2017-2022)

    • Table APAC Immunotherapy Consumption by Country (2017-2022)

    • Figure China Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Japan Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure India Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Thailand Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Singapore Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Philippines Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Immunotherapy Consumption and Growth Rate (2017-2022)

    • Table South America Immunotherapy Consumption by Country (2017-2022)

    • Figure Brazil Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Colombia Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Chile Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Argentina Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Peru Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Immunotherapy Consumption and Growth Rate (2017-2022)

    • Table GCC Immunotherapy Consumption by Country (2017-2022)

    • Figure Bahrain Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Oman Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Qatar Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Immunotherapy Consumption and Growth Rate (2017-2022)

    • Table Africa Immunotherapy Consumption by Country (2017-2022)

    • Figure Nigeria Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure South Africa Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Egypt Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Algeria Immunotherapy Consumption and Growth Rate (2017-2022)

    • Table Oceania Immunotherapy Consumption by Country (2017-2022)

    • Figure Australia Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Immunotherapy Consumption and Growth Rate (2017-2022)

    • Table Abbvie Company Details

    • Table Abbvie Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbvie Immunotherapy Main Business and Markets Served

    • Table Abbvie Immunotherapy Product Portfolio

    • Table Bristol-Myers Squibb Company Details

    • Table Bristol-Myers Squibb Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Immunotherapy Main Business and Markets Served

    • Table Bristol-Myers Squibb Immunotherapy Product Portfolio

    • Table Amgen Inc Company Details

    • Table Amgen Inc Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Immunotherapy Main Business and Markets Served

    • Table Amgen Inc Immunotherapy Product Portfolio

    • Table Roche Company Details

    • Table Roche Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Immunotherapy Main Business and Markets Served

    • Table Roche Immunotherapy Product Portfolio

    • Table Biogen Company Details

    • Table Biogen Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Immunotherapy Main Business and Markets Served

    • Table Biogen Immunotherapy Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Immunotherapy Main Business and Markets Served

    • Table Novartis Immunotherapy Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Immunotherapy Main Business and Markets Served

    • Table Pfizer Immunotherapy Product Portfolio

    • Table Merck Company Details

    • Table Merck Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Immunotherapy Main Business and Markets Served

    • Table Merck Immunotherapy Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Immunotherapy Main Business and Markets Served

    • Table Johnson & Johnson Immunotherapy Product Portfolio

    • Table Celgene Company Details

    • Table Celgene Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Immunotherapy Main Business and Markets Served

    • Table Celgene Immunotherapy Product Portfolio

    • Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Specific Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Inflammation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Central Nervous System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption Forecast by Country (2022-2028)

    • Table North America Immunotherapy Consumption Forecast by Country (2022-2028)

    • Figure United States Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Immunotherapy Consumption Forecast by Country (2022-2028)

    • Figure Germany Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Immunotherapy Consumption Forecast by Country (2022-2028)

    • Figure China Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Immunotherapy Consumption Forecast by Country (2022-2028)

    • Figure Brazil Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Immunotherapy Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Immunotherapy Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Immunotherapy Consumption Forecast by Country (2022-2028)

    • Figure Australia Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US